Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 20,851 | 21,433 | 26,255 | 35,925 | 29,202 |
| Cost of Goods | 18,875 | 15,542 | 21,141 | 29,375 | 22,171 |
| Gross Profit | 1,976 | 5,891 | 5,115 | 6,550 | 7,031 |
| Operating Expenses | 1,046 | 1,201 | -297 | 1,085 | 1,177 |
| Operating Income | 930 | 4,690 | 5,412 | 5,465 | 5,854 |
| Interest Expense | N/A | 0 | 1 | 1 | 5 |
| Other Income | 77 | 166 | 130 | 398 | 4 |
| Pre-tax Income | 1,007 | 4,856 | 5,540 | 5,862 | 5,853 |
| Income Tax | 271 | 1,283 | 1,131 | 1,551 | 1,539 |
| Net Income Continuous | 736 | 3,574 | 4,409 | 4,311 | 4,314 |
| Net Income | $736 | $3,574 | $4,409 | $4,311 | $4,314 |
| EPS Basic Total Ops | 0.04 | 0.18 | 0.21 | 0.21 | 0.22 |
| EPS Basic Continuous Ops | 0.04 | 0.18 | 0.21 | 0.21 | 0.22 |
| EPS Diluted Total Ops | 0.04 | 0.18 | 0.21 | 0.21 | 0.22 |
| EPS Diluted Continuous Ops | 0.04 | 0.18 | 0.21 | 0.21 | 0.22 |
| EBITDA(a) | $2,542 | $6,588 | $7,405 | $7,836 | $7,505 |